TP53 mutation may not only compromise its multifaceted tumor-suppressive functions but also confer oncogenic properties. Here, we demonstrate that DNA-binding domain mutations of TP53 unexpectedly confer a transcriptional regulatory function, directly driving RNA-splicing factor RBM28 overexpression. Overexpressed RBM2...
Tao Xiang, Zi-Yi He, Xiao Hu et al.· Nature Communications· 0 citations
A cell-type-resolved regulatory framework for interpreting inherited susceptibility in esophageal squamous cell carcinoma is established and RPS3A is prioritized as a susceptibility gene whose genetically regulated expression colocalizes with ESCC risk variants and increases during malignant progression.
Lina Song, Miao-Xin Pan, Yue-Ping Li et al.· Cell Reports· 1 citation
This study provides mechanistic insight into how m6A couples with an exonuclease in R-loop clearance and genome maintenance and uncovers a druggable epitranscriptional machinery that constrains the innate immune response and enables SCC immune evasion.
Jieyou Zhang, Kaiwen Bao, Yayan Hou et al.· Molecules and Cells· 0 citations
An HDGF/ENO1/H4K12la/iCAF axis that links tumor metabolic reprogramming, stromal inflammatory activation, and immunosuppression in ESCC is revealed, identifying this axis as a promising therapeutic target for overcoming immunotherapy resistance.
Zhengqing Song, Cai-Nan Li, Pujie Wu et al.· Cancer Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
